Kagenmi / iStockphoto.com
Danish biotechnology company Novozymes has won a patent dispute against China-based enzyme makers Shandong Longda Bio-Products and Jiangsu Boli Bioproducts at theSupreme People’s Court of China.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Novozymes, enzymes, patent, patent infringement, Supreme People’s Court of China, Shandong Longda Bio-Products, Jiangsu Boli Bioproducts, China
